About Voptica
Voptica is a Healthcare company based in Murcia (Spain) founded in 2010 by Pablo Artal. It operates as a personalized optical solutions are tested via adaptive optics visual simulator. Its chief executive is Pablo Artal. Voptica offers products and services including VAO® and ArtIOLs®. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Imaging. Its legal entity is VOPTICA S.L. Its competitors include EyeNetra, EYOTO, Smart Vision Labs, PlenOptika and ArcScan and 3 more; 7 of its 8 listed competitors have raised funding.
Company details
Voptica spun off in 2010 from the Laboratory of Optical Sciences of the University of Murcia. The Visual Adaptive Optics simulator is a diagnostic device that incorporates adaptive optics based visual simulator(AO) based on liquid crystal aberrometry. It allows measurement of refractive errors as well as higher order aberrations. It provides an objective characterization of the eye and a real vision experience that allows a patient to test different optical solutions before surgery. It allows the customization of visual aid devices such as glasses and contact lenses to suit the patient.
- Headquarters Murcia, Spain
- Founders Pablo Artal
- SectorsHealthcare
- Email••••••••
- Website voptica.com
- Social LinkedIn X Instagram YouTube
- Legal Name Voptica S.L.
- Latest Funding Round$1.94M (USD), Grant
Oct 2019
- InvestorsEuropean Union
& 2 more
Products & Services of Voptica
Voptica offers a comprehensive portfolio of products and services, including VAO® and ArtIOLs®.
Visual simulator for testing optical solutions before eye surgery
Customizable lenses providing extended depth of focus for vision
Apps and channels of Voptica
its YouTube channel Voptica has 78 subscribers and 30 videos.
Videos from Voptica
The most watched videos on Voptica's YouTube channel, Voptica (78 subscribers). Click a video to play it here.
More on Voptica .
Funding Insights of Voptica
- Total Rounds 4
- Last Round Grant — $1.94M
- Investors Count 3
All 4 funding rounds of Voptica with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2019 | $1.94M | Grant | – | – | |
| Nov 2017 | $2.02M | Grant | – | – | |
| Jan 2016 | $269,190 | Grant | – | – | |
| Jun 2013 | – | Series A | – | – |
3 investors in total: 3 institutional.
Investors in Voptica
Voptica has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, EIC Fund and Uninvest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium | |
- | – | uninvest.es | - | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Voptica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Voptica
1 people are tracked at Voptica (1 in leadership).
| Name | Role | Group |
|---|---|---|
Pablo Artal | Co-Founder & CEO | Leadership |
Complete people profiles for Voptica
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Voptica
3 dated milestones of Voptica across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Voptica is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $1.9M.
Competitors of Voptica
Voptica has 8 listed competitors in our database, 7 of them funded. They include EyeNetra, EYOTO, Smart Vision Labs, PlenOptika and ArcScan, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| eyenetra.com | 2011 | Somerville, United States | $7M | 3 | Refractive errors are measured using smartphone camera attachments. | |
| eyoto.com | 2014 | Birmingham, United Kingdom | $12.18M | 32 | Ophthalmic measurement solutions are developed for eye diagnosis. | |
| smartvisionlabs.com | 2013 | New York, United States | $6.1M | – | Refractive errors are tested via smartphone attachment by healthcare professionals. | |
| plenoptika.com | 2014 | Cambridge, United States | $50,383 | – | Developer of a medical devices for measuring refractive errors | |
| arcscan.com | 2007 | Golden, United States | $15.21M | 18 | Ultrasound device for micron-resolution anterior chamber imaging is provided. | |
| broadspotimaging.com | 2013 | San Francisco, United States | $8M | 8 | Ophthalmological imaging devices for anterior as well as posterior regions | |
| machinemd.com | 2019 | Bern, Switzerland | $4.77M | – | Diagnostic device for brain diseases is developed by machineMD. | |
| oculus.de | 1895 | Frankfurt Am Main, Germany | – | – | Eye diagnostic equipment is developed for ophthalmological applications. |
Detailed competitors of Voptica
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Ophthalmology
10 companies that operate in the same segment as Voptica (Ophthalmology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 | |
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized. | 2003 | Alpharetta, Georgia, United States | USD 66.8 M | USD 80.75 M | 79 | |
AI-powered portable solutions for ophthalmic screening and diagnosis are developed. | 2009 | Bengaluru, Karnataka, India | USD 25.01 M | USD 4.85 M | 135 | |
Gene therapies for ocular and neurodegenerative diseases are developed. | 2015 | New York, New York, United States | – | USD 81.39 M | 381 | |
Small molecule therapeutics for ophthalmic disorders are developed. | 1987 | Watertown, United States | – | USD 31.37 M | 165 | |
Therapies for metabolic and orphan diseases are developed by Rezolute. | 2012 | Denver, Colorado, United States | – | – | 59 | |
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms | 2010 | Bengaluru, Karnataka, India | USD 18.12 M | USD 4.78 M | 145 | |
Therapeutics for retinal diseases are developed by the company. | 2009 | Palo Alto, California, United States | USD 35.84 M | – | 109 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Voptica
Complete news archive for Voptica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Voptica
Voptica was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Voptica is headquartered in Murcia, Spain. It is registered at Murcia, Region De Murcia, Spain.
Pablo Artal is the current CEO of Voptica. They have also founded this company.
Voptica spun off in 2010 from the Laboratory of Optical Sciences of the University of Murcia. The Visual Adaptive Optics simulator is a diagnostic device that incorporates adaptive optics based visual simulator(AO) based on liquid crystal aberrometry. It allows measurement of refractive errors as well as higher order aberrations. It provides an objective characterization of the eye and a real vision experience that allows a patient to test different optical solutions before surgery. It allows the customization of visual aid devices such as glasses and contact lenses to suit the patient.
Voptica offers VAO® and ArtIOLs®.
Voptica has 3 investors. Key investors include European Union, EIC Fund, and Uninvest.
Voptica operates through Voptica S.L..